Jeffrey M. Leiden, Executive Chairman at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 6,786 shares at $420.39 ($2.8M) on 2024-02-12, disclosed to the SEC on 2024-02-14.
Scheduled sale ($2.8M) by Executive Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $419.22 | 2,009 | $842K | 29.6% |
| 2 | $419.22 | 2,009 | $842K | 29.6% |
| 3 | $420.39 | 647 | $272K | 9.6% |
| 4 | $420.39 | 647 | $272K | 9.6% |
| 5 | $419.13 | 737 | $309K | 10.9% |
| 6 | $419.13 | 737 |
| $309K |
| 10.9% |
| Total | $419.42 avg | 6,786 | $2.8M | 100% |
| Filing → |
| VRTX | SELL | 2025-11-17 | $64.1M | — | Filing → |
| VRTX | SELL | 2024-09-04 | $1.9M | — | Filing → |
| VRTX | SELL | 2024-02-16 | $7.6M | — | Filing → |